Core Historical Income Statement

CORZ Stock

USD 7.48 0.40 5.08%

Historical analysis of Core Scientific, income statement accounts such as Depreciation And Amortization of 71.3 M, Interest Expense of 59.2 M or Selling General Administrative of 111.2 M can show how well Core Scientific, Common performed in making a profits. Evaluating Core Scientific, income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Core Scientific,'s future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Core Scientific, Common latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Core Scientific, Common is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Scientific, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Core Income Statement Analysis

Core Scientific, Common Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Core Scientific, shareholders. The income statement also shows Core investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Core Scientific, Income Statement Chart

At this time, Core Scientific,'s Tax Provision is fairly stable compared to the past year. Interest Expense is likely to rise to about 59.2 M in 2025, whereas Net Interest Income is likely to drop (35 M) in 2025.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit

Total Revenue

Total revenue comprises all receipts Core Scientific, Common generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Core Scientific, Common minus its cost of goods sold. It is profit before Core Scientific, operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Core Scientific,'s income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Core Scientific, Common current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Scientific, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2023	2024	2025 (projected)
Interest Expense	37.1M	42.6M	59.2M
Depreciation And Amortization	120.1M	138.1M	71.3M

Interest Expense Depreciation And Amortization

Core Scientific, income statement Correlations

	Net Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense
Net Interest Income		-0.74	-0.98	-0.88	-0.68	-0.86	-0.49	-0.83	0.42	0.69	0.27	-0.76	0.21	-0.9	-0.79	-0.85	0.7	0.69	0.7	-0.57
Depreciation And Amortization	-0.74		0.78	0.85	0.99	0.89	0.59	0.96	-0.34	-0.82	-0.8	0.71	-0.76	0.9	0.58	0.89	-0.82	-0.85	-0.82	0.45
Interest Expense	-0.98	0.78		0.91	0.72	0.9	0.53	0.86	-0.41	-0.74	-0.39	0.79	-0.33	0.94	0.79	0.88	-0.74	-0.75	-0.74	0.58
Selling General Administrative	-0.88	0.85	0.91		0.82	0.9	0.4	0.87	-0.61	-0.95	-0.56	0.96	-0.51	0.98	0.91	0.99	-0.95	-0.94	-0.95	0.47
Selling And Marketing Expenses	-0.68	0.99	0.72	0.82		0.89	0.63	0.96	-0.26	-0.79	-0.84	0.67	-0.81	0.88	0.51	0.85	-0.79	-0.83	-0.79	0.48
Total Revenue	-0.86	0.89	0.9	0.9	0.89		0.76	0.98	-0.21	-0.78	-0.61	0.77	-0.57	0.97	0.68	0.88	-0.78	-0.82	-0.78	0.75
Gross Profit	-0.49	0.59	0.53	0.4	0.63	0.76		0.75	0.47	-0.24	-0.45	0.2	-0.43	0.58	0.09	0.36	-0.23	-0.31	-0.24	0.91
Other Operating Expenses	-0.83	0.96	0.86	0.87	0.96	0.98	0.75		-0.21	-0.77	-0.7	0.71	-0.66	0.95	0.61	0.87	-0.77	-0.81	-0.78	0.67
Operating Income	0.42	-0.34	-0.41	-0.61	-0.26	-0.21	0.47	-0.21		0.71	0.18	-0.74	0.15	-0.44	-0.78	-0.65	0.72	0.65	0.71	0.35
Net Income From Continuing Ops	0.69	-0.82	-0.74	-0.95	-0.79	-0.78	-0.24	-0.77	0.71		0.68	-0.95	0.65	-0.89	-0.88	-0.96	1.0	1.0	1.0	-0.27
Ebit	0.27	-0.8	-0.39	-0.56	-0.84	-0.61	-0.45	-0.7	0.18	0.68		-0.45	1.0	-0.6	-0.26	-0.61	0.68	0.73	0.68	-0.21
Research Development	-0.76	0.71	0.79	0.96	0.67	0.77	0.2	0.71	-0.74	-0.95	-0.45		-0.41	0.88	0.97	0.95	-0.95	-0.93	-0.95	0.35
Ebitda	0.21	-0.76	-0.33	-0.51	-0.81	-0.57	-0.43	-0.66	0.15	0.65	1.0	-0.41		-0.56	-0.22	-0.56	0.65	0.7	0.65	-0.18
Cost Of Revenue	-0.9	0.9	0.94	0.98	0.88	0.97	0.58	0.95	-0.44	-0.89	-0.6	0.88	-0.56		0.82	0.97	-0.89	-0.9	-0.89	0.61
Total Operating Expenses	-0.79	0.58	0.79	0.91	0.51	0.68	0.09	0.61	-0.78	-0.88	-0.26	0.97	-0.22	0.82		0.89	-0.88	-0.84	-0.88	0.3
Reconciled Depreciation	-0.85	0.89	0.88	0.99	0.85	0.88	0.36	0.87	-0.65	-0.96	-0.61	0.95	-0.56	0.97	0.89		-0.96	-0.96	-0.96	0.4
Income Before Tax	0.7	-0.82	-0.74	-0.95	-0.79	-0.78	-0.23	-0.77	0.72	1.0	0.68	-0.95	0.65	-0.89	-0.88	-0.96		1.0	1.0	-0.27
Total Other Income Expense Net	0.69	-0.85	-0.75	-0.94	-0.83	-0.82	-0.31	-0.81	0.65	1.0	0.73	-0.93	0.7	-0.9	-0.84	-0.96	1.0		1.0	-0.33
Net Income	0.7	-0.82	-0.74	-0.95	-0.79	-0.78	-0.24	-0.78	0.71	1.0	0.68	-0.95	0.65	-0.89	-0.88	-0.96	1.0	1.0		-0.28
Income Tax Expense	-0.57	0.45	0.58	0.47	0.48	0.75	0.91	0.67	0.35	-0.27	-0.21	0.35	-0.18	0.61	0.3	0.4	-0.27	-0.33	-0.28

Click cells to compare fundamentals

Core Scientific, Account Relationship Matchups

Core Scientific, income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Tax Provision	15.8M	(17.1M)	683K	859K	773.1K	811.8K
Net Interest Income	(44.4M)	(96.8M)	(86.2M)	(37.1M)	(33.4M)	(35.0M)
Interest Expense	44.4M	96.8M	86.2M	37.1M	42.6M	59.2M
Selling General Administrative	60.5M	226.0M	93.9M	110.4M	127.0M	111.2M
Total Revenue	544.5M	640.3M	502.4M	510.7M	587.3M	496.8M
Gross Profit	238.9M	8.4M	123.5M	121.1M	139.2M	110.3M
Operating Income	166.6M	(244.6M)	9.0M	(19.2M)	(17.3M)	(18.1M)
Net Income From Continuing Ops	47.3M	(2.1B)	(246.5M)	(1.3B)	(1.2B)	(1.1B)
Research Development	7.7M	27.0M	7.2M	11.8M	13.6M	13.0M
Cost Of Revenue	305.6M	631.9M	378.9M	389.6M	448.0M	386.5M
Total Operating Expenses	72.2M	884.9M	114.5M	140.3M	161.3M	266.6M
Reconciled Depreciation	33.4M	226.1M	96.4M	120.1M	138.1M	106.8M
Income Before Tax	63.1M	(2.2B)	(245.8M)	(1.3B)	(1.2B)	(1.1B)
Total Other Income Expense Net	(68.4M)	(1.8B)	(254.8M)	(1.3B)	(1.2B)	(1.1B)
Net Income	47.3M	(2.1B)	(246.5M)	(1.3B)	(1.2B)	(1.1B)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Core Stock Analysis

When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Core Historical Income Statement

About Core Income Statement Analysis

Core Scientific, Income Statement Chart

Total Revenue

Gross Profit

Core Scientific, income statement Correlations

Core Scientific, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Core Scientific, income statement Accounts

Also Currently Popular

Additional Tools for Core Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Before Tax	+ 1.0	Net Income From Continuing Ops
Total Other Income Expense Net	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops
Ebitda	+ 1.0	Ebit
Total Other Income Expense Net	+ 1.0	Income Before Tax
Net Income	+ 1.0	Income Before Tax

Interest Expense	- 0.98	Net Interest Income
Net Income	- 0.96	Reconciled Depreciation
Total Other Income Expense Net	- 0.96	Reconciled Depreciation
Income Before Tax	- 0.96	Reconciled Depreciation
Reconciled Depreciation	- 0.96	Net Income From Continuing Ops
Net Income	- 0.95	Research Development